Smith & Nephew (MEX:SN1 N) Short-Term Debt: MXN8,864 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:SN1 N Smith & Nephew PLC MEX:SN1 N
83 GF Score
Price MXN256.55
GF Value MXN256.12
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew Short-Term Debt?

Smith & Nephew MEX:SN1 N 83 Short-Term Debt is MXN8,864 Mil as of Jun. 2026. GuruFocus rates MEX:SN1 N with a GF Score™ of 83/100 and a GF Value™ of MXN256.12. The stock has 3 warning signs investors should review.

Smith & Nephew's Short-Term Debt for the quarter that ended in Jun. 2026 was MXN8,864 Mil.

Smith & Nephew's quarterly Short-Term Debt declined from Jun. 2025 (MXN1,751 Mil) to Dec. 2025 (MXN1,494 Mil) but then increased from Dec. 2025 (MXN1,494 Mil) to Jun. 2026 (MXN8,864 Mil).

Smith & Nephew's annual Short-Term Debt declined from Dec. 2023 (MXN12,052 Mil) to Dec. 2024 (MXN42 Mil) but then increased from Dec. 2024 (MXN42 Mil) to Dec. 2025 (MXN1,494 Mil).

Smith & Nephew Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Smith & Nephew Short-Term Debt Related Terms

Smith & Nephew Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Smith & Nephew's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smith & Nephew Short-Term Debt Chart

Smith & Nephew Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,923.59 2,164.06 12,051.72 41.71 1,494.47

Smith & Nephew Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,008.99 41.71 1,751.12 1,494.47 8,864.09
MEX:SN1 N
83GF Score
Smith & Nephew PLC MEX:SN1 N
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN8,864 Mil mean?
Smith & Nephew (MEX:SN1 N) has a Short-Term Debt of MXN8,864 Mil as of Jun. 2026.
Is Smith & Nephew's Short-Term Debt too high?
Smith & Nephew's current Short-Term Debt is MXN8,864 Mil. Overall, Smith & Nephew has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Smith & Nephew's Short-Term Debt compare to ABT and SYK?
Smith & Nephew's Short-Term Debt of MXN8,864 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Smith & Nephew's current Short-Term Debt is MXN8,864 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smith & Nephew stock overvalued right now?
Smith & Nephew (MEX:SN1 N) has a current Short-Term Debt of MXN8,864 Mil. The stock's GF Value™ is MXN256.12, compared to a current price of MXN256.55 — trading 0.2% above its estimated fair value. The current Short-Term Debt is MXN8,864 Mil. Smith & Nephew's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Smith & Nephew (MEX:SN1 N), the current Short-Term Debt is MXN8,864 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Smith & Nephew (MEX:SN1 N) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be overvalued. The current stock price of MXN256.55 is trading 0.2% above its estimated GF Value™ of MXN256.12.

Key valuation signals for MEX:SN1 N:

  • Short-Term Debt: MXN8,864 Mil
  • GF Value™: MXN256.12 vs. price of MXN256.55 (0.2% above fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the MEX:SN1 N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
83GF Score

Get the complete analysis for MEX:SN1 N

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN256.55
Price
MXN256.12
GF Value